CoreCap Advisors »

Immunovant shares owned by CoreCap Advisors

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by CoreCap Advisors from 13F filings

Historical chart of CoreCap Advisors investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by CoreCap Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by CoreCap Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $124k 4.4k 28.51
2024-06-30 $204k 7.7k 26.40
2024-03-31 $260k 8.0k 32.31
2023-12-31 $270k 6.4k 42.13
2023-09-30 $221k 5.8k 38.39
2023-06-30 $292k 15k 18.97

More positions owned by CoreCap Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Select Sector Spdr Tr Technology (XLK)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Apple (AAPL)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Scottsdale Fds Lg-term Cor Bd (VCLT)
Amazon (AMZN)

View all positions for CoreCap Advisors

Top funds holding Immunovant

Vanguard Group
BlackRock
BlackRock
Armistice Capital
T. Rowe Price Investment Management
Deep Track Capital
State Street Corporation
Perceptive Advisors
Viking Global Investors
Alpine Partners VI
Geode Capital Management
Woodline Partners
Paradigm Biocapital Advisors
Pictet Asset Management Holding SA
Baker Bros. Advisors

View all funds holding Immunovant